• SENSEX 77,928.15
    273.55 (+0.35%)
  • BANKNIFTY 57,147.50
    -58.40 (--0.10%)
  • Indo-MIM
    757.50 757.50(%)
  • Bajaj Finserv
    1,891.35 1,598.15(%)
  • Bajaj Finance
    1,067.05 1,102.45(%)
  • ICICI Bank
    1,423.00 1,187.55(%)
  • HDFC Bank
    758.00 1,020.35(%)
  • Adani Green
    1,350.10 767.00(%)
  • Reliance Industries
    1,298.00 1,611.20(%)
  • DLF
    652.05 489.30(%)
  • TBO Tek
    1,473.20 1,005.50(%)
  • Eicher Motors
    7,929.00 8,232.80(%)
  • Kalyan Jewellers
    649.00 649.00(%)
  • M & M
    3,325.00 3,840.00(%)
  • TVS Motor Co.
    4,219.00 4,219.00(%)
  • Infosys
    1,187.00 1,727.85(%)
  • Coforge
    1,763.70 1,988.90(%)
  • Jubilant Food.
    433.80 408.50(%)
  • Waaree Energies
    2,563.00 2,402.00(%)
  • Cholaman.Inv.&Fn
    1,758.65 1,299.80(%)
  • Redington
    338.20 338.20(%)
  • SBI
    1,030.00 1,234.80(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Jenburkt Pharmaceuticals Ltd Pharmaceuticals - Indian - Formulations

  • Indian Private
  • BSE Code : 4394.0
  • ISIN : INE354A01013
1,081.70 22 (2.05%)
  • As on 30 Jul 2026 (EOD)

  • Today’s Low

    1,036.05

  • Today’s High

    1,085.00

  • Open

    1,069.45

  • Perv Close

    1,060.00

  • 52W Low

    944.00

  • 52W High

    1,340.00

Key Indicators

  • P/E(TTM)

    12.69

  • Mar.Cap (₹Cr.)

    477.39

  • Div & Yield %

    1.91

  • Book Value(₹)

    446.48

  • Debt-Equity Ratio

    2.05

  • AGM Date

    30-Jul-2026

  • EPS

    85.23

  • P/E Ratio

    12.69

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    477.39

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    4.41

  • BV (₹)

    446.50

  • Sales( ₹ in Cr.)

    168.74

  • NP (in Cr.)

    37.61

  • NP Var(%)

    20.0

  • Div%

    207.0

  • CPS (₹)

    92.30

  • EPS (₹)

    85.20

  • Traded Value (₹ in Lakhs)

    477.39

  • 52 Week High

    1,340.00

  • 52 Week Low

    944.00

  • Price BSE

    1082.0

  • Price NSE

    0.00

  • Market Capital( in Cr.)

    477.39

  • P/C Ratio

    11.70

  • P/E Ratio

    12.70

  • Price Vs.BV

    85.20

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar
INCOME :            
Sales Turnover 151.69 141.97 136.75 123.98 109.29 118.89
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 151.69 141.97 136.75 123.98 109.29 118.89
Other Income 6.72 4.67 5.12 4.95 4.31 4.22
Stock Adjustments 0.12 0.39 -1.34 2.28 -3.18 0.49
Total Income 158.53 147.03 140.53 131.21 110.42 123.60
EXPENDITURE :            
Raw Materials 29.77 30.80 31.67 33.72 26.91 33.55
Power and Fuel Cost 0.71 0.75 0.76 0.61 0.50 0.59
Employee Cost 45.54 42.49 38.81 36.49 32.38 36.51
Other Manufacturing Expenses 4.30 3.58 4.28 3.85 2.50 2.98
Selling and Administration Expenses 30.27 31.04 29.03 24.32 23.03 25.46
Miscellaneous Expenses 0.83 0.58 0.50 0.01 0.95 0.54
Employee Benefit Expenses 45.54 42.49 38.81 36.49 32.38 36.51
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 111.41 109.24 105.05 99.01 86.26 99.63
Operating Profit 47.11 37.79 35.49 32.20 24.15 23.97
Interest 0.45 0.27 0.37 0.43 0.47 0.53
Gross Profit 46.66 37.52 35.12 31.77 23.68 23.44
Depreciation 2.73 2.34 2.26 1.90 2.04 2.30
Profit Before Tax 43.93 35.18 32.86 29.87 21.64 21.14
Current Tax 12.08 9.72 8.48 7.28 5.53 5.90
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -0.21 -0.52 -0.23 0.30 -0.39 0.37
Reported Net Profit 32.06 25.98 24.61 22.30 16.50 14.87
Extraordinary Items 0.59 0.04 0.00 0.14 0.00 0.00
Adjusted Net Profit 31.47 25.94 24.61 22.16 16.50 14.87
Adjustment below Net Profit 0.00 0.00 -14.34 0.00 0.00 -1.60
P & L Balance brought forward 134.12 113.11 108.53 90.91 74.41 69.42
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 3.84 4.96 5.69 4.68 0.00 8.28
P & L Balance carried down 162.34 134.12 113.10 108.53 90.91 74.41
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 180.00 153.00 144.00 120.00 102.00 81.00
Dividend Per Share(Rs) 18.00 15.30 14.40 12.00 10.20 8.10
Earnings Per Share-Unit Curr 72.65 58.86 55.76 48.58 35.96 32.40
Earnings Per Share(Adj)-Unit Curr 72.65 58.86 55.76 48.58 35.96 32.40
Book Value 389.23 328.42 277.32 255.77 214.55 174.32
Book Value(Adj)-Unit Curr 389.23 328.42 277.32 255.77 214.55 174.32

Shareholding Pattern

  • Promoter Group

    46.62%

  • Public Share Holding

    53.38%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 616,128 13.96 616,128 1
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 1,441,322 32.66 1,441,322 9
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 2,057,450 46.62 2,057,450 10
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 0 0.00 0 0
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 5,355 0.12 5,355 2
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 5,355 0.12 5,355 2
2] Non Institution
Bodies Corporate 148,994 3.38 148,394 57
Clearing Members 3,956 0.09 3,956 6
Directors of their Relatives 900 0.02 900 2
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 136,268 3.09 136,268 180
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 54,152 1.23 54,152 193
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 454,445 10.30 454,445 9
Individuals holding nominal share capital up to Rs. 1 lakh 1,357,401 30.76 1,275,601 6,640
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 90,450 2.05 90,450 2
Others 103,929 2.35 103,929 2
Sub Total 2,350,495 53.26 2,268,095 7,091
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 4,413,300 100.00 4,330,900 7,103

Company Background

Jenburkt Pharmaceuticals LtdPharmaceuticals - Indian - Formulations

  • Jenburkt Pharmaceuticals Ltd
  • BSE Code : 4394.0
  • ISIN : INE354A01013

  • Incorporation Year

    1985

  • Registered Office

    Nirmala Apartment P B No 37396
    93 Jayprakash Road Andheri(W), Mumbai,
    Maharashtra-400058

  • Telephone

    91-22-66943121/67603603

  • FAX

    91-22-66943127

  • Chairman

    Ashish U Bhuta

  • Managing Director

    Ashish U Bhuta

  • Company Secretary

    Ashish R Shah

  • Auditor

    D R Mehta & Associates

  • Face Value

    10

  • Listing

    BSE

  • Registrar

    Bigshare Services Pvt Ltd
    Office No S6-2,
    Pinnacle Busine.Park,Mahakali Caves Road
    Mumbai - Mumbai - 400093

Jenburkt Pharmaceuticals Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Jenburkt Pharma 1,081.70 158.41 151.69 13.74 27.18
Abbott India 27,566.00 7,217.19 6,929.05 37.74 43.78
Astrazeneca Phar 8,090.05 2,304.07 2,275.58 107.85 27.86
P & G Health Ltd 6,502.50 944.52 934.17 33.02 71.75
Glaxosmi. Pharma 2,609.65 3,932.76 3,790.20 43.69 58.17
Cipla 1,466.00 20,102.60 18,979.95 38.53 13.88
Amrutanjan Healt 518.30 469.50 451.82 25.88 21.89
Fermenta Biotec. 465.55 474.15 450.25 21.32 18.77
Bliss GVS Pharma 454.10 773.53 729.81 49.74 12.51
Guj. Themis Bio. 351.75 152.47 150.80 82.18 27.21
Ambalal Sarabhai 33.64 19.52 3.94 23.52 6.77